- Home
- Publications
- Publication Search
- Publication Details
Title
High-dose vitamin C enhances cancer immunotherapy
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 12, Issue 532, Pages eaay8707
Publisher
American Association for the Advancement of Science (AAAS)
Online
2020-02-27
DOI
10.1126/scitranslmed.aay8707
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model
- (2020) Rebecca A. Luchtel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors
- (2019) Patrick Arnaud-Coffin et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer
- (2019) Feng Wang et al. BMC CANCER
- Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy
- (2019) Yan-ping Xu et al. JOURNAL OF CLINICAL INVESTIGATION
- Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo
- (2018) Nigel G. Kooreman et al. Cell Stem Cell
- Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
- (2018) Michael J. Overman et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma: Updated Survival, Response, and Safety Data in a Phase I Dose-Escalation Study
- (2018) Margaret K. Callahan et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly
- (2018) Niraj Shenoy et al. CANCER CELL
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge
- (2018) Anitra C. Carr et al. Frontiers in Physiology
- Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
- (2018) S Adams et al. ANNALS OF ONCOLOGY
- The role of vitamin C in the treatment of pain: new insights
- (2017) Anitra C. Carr et al. Journal of Translational Medicine
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
- (2017) Michael J Overman et al. LANCET ONCOLOGY
- Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth
- (2017) Giovanni Germano et al. NATURE
- Ascorbate regulates haematopoietic stem cell function and leukaemogenesis
- (2017) Michalis Agathocleous et al. NATURE
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- (2017) Joaquim Bellmunt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Vitamin C and Immune Function
- (2017) Anitra Carr et al. Nutrients
- Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature
- (2016) Maud-Emmanuelle Gilles et al. CANCER RESEARCH
- Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer
- (2016) Jing Liu et al. CANCER RESEARCH
- Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of ascorbate-dependent mice
- (2016) Elizabeth J. Campbell et al. FREE RADICAL BIOLOGY AND MEDICINE
- N-Acetyl cysteine does not prevent liver toxicity from chronic low-dose plus subacute high-dose paracetamol exposure in young or old mice
- (2016) Alice Elizabeth Kane et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Control of Foxp3 stability through modulation of TET activity
- (2016) Xiaojing Yue et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Vitamin C Facilitates Demethylation of theFoxp3Enhancer in a Tet-Dependent Manner
- (2016) Varun Sasidharan Nair et al. JOURNAL OF IMMUNOLOGY
- Vitamin C: the known and the unknown and Goldilocks
- (2016) SJ Padayatty et al. ORAL DISEASES
- Regulation of the Epigenome by Vitamin C
- (2015) Juan I. Young et al. Annual Review of Nutrition
- Antitumor effect of pharmacologic ascorbate in the B16 murine melanoma model
- (2015) Oscar K. Serrano et al. FREE RADICAL BIOLOGY AND MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
- (2015) J. Yun et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Vitamin C treatment of mouse bone marrow-derived dendritic cells enhanced CD8+ memory T cell production capacity of these cells in vivo
- (2014) Young-Joo Jeong et al. IMMUNOBIOLOGY
- Ascorbic Acid: Its Role in Immune System and Chronic Inflammation Diseases
- (2014) Angela Sorice et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
- (2014) K. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antioxidants Accelerate Lung Cancer Progression in Mice
- (2014) V. I. Sayin et al. Science Translational Medicine
- Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells
- (2013) Kathryn Blaschke et al. NATURE
- Vitamin C Promotes Maturation of T-Cells
- (2012) Jared Manning et al. ANTIOXIDANTS & REDOX SIGNALING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More